Loring Wolcott & Coolidge Fiduciary Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $786K | Hold |
|
|||||
|
2025
Q1 | $754K | Sell |
|
|||||
|
2024
Q4 | $811K | Hold |
|
|||||
|
2024
Q3 | $755K | Sell |
|
|||||
|
2024
Q2 | $621K | Buy |
|
|||||
|
2024
Q1 | $575K | Hold |
|
|||||
|
2023
Q4 | $672K | Sell |
|
|||||
|
2023
Q3 | $758K | Sell |
|
|||||
|
2023
Q2 | $1.07M | Hold |
|
|||||
|
2023
Q1 | $1.15M | Sell |
|
|||||
|
2022
Q4 | $1.43M | Sell |
|
|||||
|
2022
Q3 | $1.07M | Sell |
|
|||||
|
2022
Q2 | $1.08M | Sell |
|
|||||
|
2022
Q1 | $1.28M | Buy |
|
|||||
|
2021
Q4 | $1.26M | Buy |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q2 | $1.13M | Buy |
|
|||||
|
2021
Q1 | $1.03M | Sell |
|
|||||
|
2020
Q4 | $968K | Sell |
|
|||||
|
2020
Q3 | $1.08M | Buy |
|
|||||
|
2020
Q2 | $1.27M | Buy |
|
|||||
|
2020
Q1 | $794K | Sell |
|
|||||
|
2019
Q4 | $781K | Sell |
|
|||||
|
2019
Q3 | $800K | Buy |
|
|||||
|
2019
Q2 | $800K | Buy |
|
|||||
|
2019
Q1 | $749K | Sell |
|
|||||
|
2018
Q4 | $769K | Sell |
|
|||||
|
2018
Q3 | $3.14M | Sell |
|
|||||
|
2018
Q2 | $13M | Sell |
|
|||||
|
2018
Q1 | $28.3M | Sell |
|
|||||
|
2017
Q4 | $30.8M | Sell |
|
|||||
|
2017
Q3 | $39.5M | Sell |
|
|||||
|
2017
Q2 | $38.2M | Sell |
|
|||||
|
2017
Q1 | $41.7M | Sell |
|
|||||
|
2016
Q4 | $51.2M | Sell |
|
|||||
|
2016
Q3 | $58.8M | Buy |
|
|||||
|
2016
Q2 | $54.8M | Buy |
|
|||||
|
2016
Q1 | $60M | Buy |
|
|||||
|
2015
Q4 | $63.2M | Buy |
|
|||||
|
2015
Q3 | $59M | Hold |
|
|||||
|
2015
Q2 | $59M | Buy |
|
|||||
|
2015
Q1 | $36.3M | Buy |
|
|||||
|
2014
Q4 | $10M | Buy |
|
|||||
|
2014
Q3 | $5.5M | Buy |
|
|||||
|
2014
Q2 | $1.66M | Buy |
|
|||||
|
2014
Q1 | $1.05M | Buy |
|
|||||
|
2013
Q4 | $1.06M | Buy |
|
|||||
|
2013
Q3 | $786K | Buy |
|
|||||
|
2013
Q2 | $639K | Buy |
|